tradingkey.logo

Cosmos Health Inc

COSM
0.487USD
-0.020-3.96%
收盤 12/19, 16:00美東報價延遲15分鐘
15.52M總市值
虧損本益比TTM

Cosmos Health Inc

0.487
-0.020-3.96%

關於 Cosmos Health Inc 公司

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Cosmos Health Inc簡介

公司代碼COSM
公司名稱Cosmos Health Inc
上市日期May 19, 2010
CEOSiokas (Grigorios)
員工數量149
證券類型Ordinary Share
年結日May 19
公司地址5 Agiou Georgiou, Pilea
城市THESSALONIKI
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Greece
郵編554 38
電話303125363102
網址https://www.cosmosholdingsinc.com/
公司代碼COSM
上市日期May 19, 2010
CEOSiokas (Grigorios)

Cosmos Health Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.46M
+4.89%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.46M
+4.89%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
Greece
921.13K
89.16%
United Arab Emirates (
130.79K
12.66%
SKOPJE North Macedonia
16.22K
1.57%
Croatia (Country)
10.68K
1.03%
Bulgaria
-49.00
0.00%
其他
-45.60K
-4.41%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Siokas (Grigorios)
18.98%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
其他
73.33%
持股股東
持股股東
佔比
Siokas (Grigorios)
18.98%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
其他
73.33%
股東類型
持股股東
佔比
Individual Investor
25.71%
Investment Advisor
1.55%
Hedge Fund
0.91%
Investment Advisor/Hedge Fund
0.70%
Venture Capital
0.19%
Research Firm
0.12%
Bank and Trust
0.02%
其他
70.80%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
39
1.21M
8.69%
--
2025Q3
40
1.21M
10.09%
+200.56K
2025Q2
40
1.01M
10.29%
-1.71M
2025Q1
38
2.72M
7.86%
+891.30K
2024Q4
38
1.62M
11.55%
-779.82K
2024Q3
39
2.40M
4.16%
+1.81M
2024Q2
40
591.35K
13.72%
-13.70K
2024Q1
40
605.05K
14.49%
-1.85M
2023Q4
39
1.97M
8.60%
+1.22M
2023Q3
36
746.56K
8.56%
-123.02K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Siokas (Grigorios)
6.16M
20.38%
--
--
Aug 01, 2025
Bovopoulos (Andreas D)
1.45M
4.81%
-427.73K
-22.74%
Aug 13, 2025
Terzis (Georgios)
727.26K
2.41%
--
--
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.89%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
134.83K
0.45%
--
--
Jun 30, 2025
Citadel Advisors LLC
96.73K
0.32%
+96.73K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
191.56K
0.63%
-2.56K
-1.32%
Jun 30, 2025
XTX Markets LLC
36.70K
0.12%
+36.70K
--
Jun 30, 2025
Bardakis (Nikolaos)
45.00K
0.15%
--
--
Aug 01, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
公告日期
類型
比率
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1

常見問題

Cosmos Health Inc的前五大股東是誰?

Cosmos Health Inc的前五大股東如下:
Siokas (Grigorios)
持有股份:6.16M
佔總股份比例:20.38%。
Bovopoulos (Andreas D)
持有股份:1.45M
佔總股份比例:4.81%。
Terzis (Georgios)
持有股份:727.26K
佔總股份比例:2.41%。
BlackRock Institutional Trust Company, N.A.
持有股份:267.80K
佔總股份比例:0.89%。
The Vanguard Group, Inc.
持有股份:134.83K
佔總股份比例:0.45%。

Cosmos Health Inc的前三大股東類型是什麼?

Cosmos Health Inc 的前三大股東類型分別是:
Siokas (Grigorios)
Bovopoulos (Andreas D)
Terzis (Georgios)

有多少機構持有Cosmos Health Inc(COSM)的股份?

截至2025Q4,共有39家機構持有Cosmos Health Inc的股份,合計持有的股份價值約為1.21M,占公司總股份的8.69% 。與2025Q3相比,機構持股有所增加,增幅為-1.40%。

哪個業務部門對Cosmos Health Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Cosmos Health Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI